hotspot -WSS

hotspot

author：explore 2025-09-14 11:51:17 - browse：2

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Why depression after traumatic brain injury is distinct

entertainment

WSS

Many immigrants are left out of maternal health programs

How many hemophilia patients actually want gene therapy?

5 wounded, 2 critically, in Michigan shopping center shooting

FDA advisers back CAR

American TikTok star stuck in Dubai for months following rental car altercation

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

hotspot

hotspot

hotspot

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

United colonoscopy coverage change 'may cost lives,' doctors say

House GOP plan to stem drug shortages differs from Democrats’

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Bristol, Sangamo, Gilead, and more

In age of alternative facts, a scholarly course on calling out crap

Judge orders hearing on Trump's motion to disqualify Fulton County DA

entertainment

John Green on his newest strategy for fighting tuberculosis

As AI in medicine takes off, can 'human in the loop' prevent harm?

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

President Biden's budget: Here's what you might have missed

Doctors in states that ban abortion can still help patients

RaDonda Vaught links Vanderbilt hospital issues to patient death

Wikipedia

hotspot

entertainment

knowledge